These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34862606)

  • 1. The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
    Subramaniam KS; Antoniou MN; McGrath JA; Lwin SM
    Br J Dermatol; 2022 Apr; 186(4):609-619. PubMed ID: 34862606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis and molecular genetics of epidermolysis bullosa.
    Pulkkinen L; Uitto J
    Matrix Biol; 1999 Feb; 18(1):29-42. PubMed ID: 10367729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Santucci C; Alexandru M; Chen X; Mellerio JE; Karagiannis SN; Jacków-Malinowska J
    Hum Immunol; 2024 May; 85(3):110805. PubMed ID: 38703415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hereditary epidermolysis bullosa: updates and future prospects.
    Hsu CK; Wang SP; Lee JY; McGrath JA
    Am J Clin Dermatol; 2014 Feb; 15(1):1-6. PubMed ID: 24402870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
    Cutlar L; Greiser U; Wang W
    Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.
    So JY; Nazaroff J; Iwummadu CV; Harris N; Gorell ES; Fulchand S; Bailey I; McCarthy D; Siprashvili Z; Marinkovich MP; Tang JY; Chiou AS
    Orphanet J Rare Dis; 2022 Oct; 17(1):377. PubMed ID: 36253825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eye Involvement and Management in Inherited Epidermolysis Bullosa.
    Bachir Y; Daruich A; Marie C; Robert MP; Bremond-Gignac D
    Drugs; 2022 Aug; 82(12):1277-1285. PubMed ID: 36074321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.
    Gayathri E; Anbukkarasi K; Lilly SM
    Indian J Pathol Microbiol; 2023; 66(2):360-362. PubMed ID: 37077084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermolysis bullosa and cancer.
    Mallipeddi R
    Clin Exp Dermatol; 2002 Nov; 27(8):616-23. PubMed ID: 12472531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.
    Hwang A; Kwon A; Miller CH; Reimer-Taschenbrecker A; Paller AS
    Orphanet J Rare Dis; 2024 May; 19(1):206. PubMed ID: 38769503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature.
    Bonamonte D; Filoni A; De Marco A; Lospalluti L; Nacchiero E; Ronghi V; Colagrande A; Giudice G; Cazzato G
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.
    Robertson SJ; Orrin E; Lakhan MK; O'Sullivan G; Felton J; Robson A; Greenblatt DT; Bernardis C; McGrath JA; Martinez AE; Mellerio JE
    Acta Derm Venereol; 2021 Aug; 101(8):adv00523. PubMed ID: 34230977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.
    Tang JY; Marinkovich MP; Lucas E; Gorell E; Chiou A; Lu Y; Gillon J; Patel D; Rudin D
    Orphanet J Rare Dis; 2021 Apr; 16(1):175. PubMed ID: 33849616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermolysis Bullosa: Pediatric Perspectives.
    Hon KL; Chu S; Leung AKC
    Curr Pediatr Rev; 2022; 18(3):182-190. PubMed ID: 34036913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular therapies for inherited epidermolysis bullosa.
    Has C
    G Ital Dermatol Venereol; 2016 Aug; 151(4):397-402. PubMed ID: 27149615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa.
    Kim M; Murrell DF
    Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.
    Condorelli AG; Dellambra E; Logli E; Zambruno G; Castiglia D
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts.
    Condorelli AG; Logli E; Cianfarani F; Teson M; Diociaiuti A; El Hachem M; Zambruno G; Castiglia D; Odorisio T
    Br J Dermatol; 2019 Nov; 181(5):1017-1027. PubMed ID: 30816994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
    Bartolo J; Farricha V; Carvalhal S; Moura C; Abecasis N
    Dermatol Ther; 2020 Nov; 33(6):e14093. PubMed ID: 32720460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy.
    Raoufinia R; Rahimi HR; Keyhanvar N; Moghbeli M; Abdyazdani N; Rostami M; Naghipoor K; Forouzanfar F; Foroudi S; Saburi E
    Stem Cell Rev Rep; 2024 Jul; 20(5):1200-1212. PubMed ID: 38430362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.